Evidence map›Paper›PMID 24006264›Full record

ArticleJournal of cell science2013

Expression of OA1 limits the fusion of a subset of MVBs with lysosomes - a mechanism potentially involved in the initial biogenesis of melanosomes.

Thomas Burgoyne, Rushee Jolly, Belen Martin-Martin, Miguel C Seabra, Rosanna Piccirillo, Maria Vittoria Schiaffino, Clare E Futter

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. G protein-coupled receptors: a gateway to targeting oncogenic EVs?Extracellular vesicles and circulating nucleic acids · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Melanosome Biogenesis in the Pigmentation of Mammalian Skin.Integrative and comparative biology · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Novel genetic variants ofAmerican journal of cancer research · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Ocular Albinism Type 1 Regulates Melanogenesis in Mouse Melanocytes.International journal of molecular sciences · 2016
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Thomas BurgoyneUCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK.
Rushee Jolly
Belen Martin-Martin
Miguel C Seabra
Rosanna Piccirillo
Maria Vittoria Schiaffino
Clare E Futter
Institute of Ophthalmology · MXVita-Salute San Raffaele University · ITNational Institutes of Health · USUniversity College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D011841/1Biotechnology and Biological Sciences Research Council D011841Telethon GGP08156Wellcome Trust 093445
6 · The paper itself

Abstract

Multivesicular endosomes/bodies (MVBs) deliver proteins, such as activated EGF receptor (EGFR), to the lysosome for degradation, and, in pigmented cells, MVBs containing PMEL are an initial stage in melanosome biogenesis. The mechanisms regulating numbers and fate of different populations of MVB are unclear. Here, we focus on the role of the G-protein-coupled receptor OA1 (also known as GPR143), which is expressed exclusively in pigmented cells and mutations in which cause the most common type of ocular albinism. When exogenously expressing PMEL, HeLa cells have been shown to form MVBs resembling early stage melanosomes. To focus on the role of OA1 in the initial stages of melanosome biogenesis we take advantage of the absence of the later stages of melanosome maturation in HeLa cells to determine whether OA1 activity can regulate MVB number and fate. Expression of wild-type but not OA1 mutants carrying inactivating mutations or deletions causes MVB numbers to increase. Whereas OA1 expression has no effect on delivery of EGFR-containing MVBs to the lysosome, it inhibits the lysosomal delivery of PMEL and PMEL-containing MVBs accumulate. We propose that OA1 activity delays delivery of PMEL-containing MVBs to the lysosome to allow time for melanin synthesis and commitment to melanosome biogenesis.

Indexed as

EndosomesErbB ReceptorsEye ProteinsGene Expression Regulation, Developmentalgp100 Melanoma AntigenHeLa CellsHumansLysosomesMelanosomesMembrane GlycoproteinsMultivesicular BodiesMutationEGFR protein, humanErbB ReceptorsEye Proteinsgp100 Melanoma AntigenGPR143 protein, humanMembrane GlycoproteinsPMEL protein, humanLysosomesMultivesicular bodiesOA1

Identifiers

PMID24006264
PMCPMC3828590
OpenAlexW2021069524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.